Stocknear Logo Stocknear
/
Popular
Login

Eli Lilly and

839.96
105.06 (14.30%)
At close: Apr 17, 2025, 3:59 PM
844.40
0.53%
After-hours: Apr 17, 2025, 07:59 PM EDT

Eli Lilly and Revenue Breakdown

Period Ending Sep 30, 2024 Mar 31, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Jun 30, 2011 Mar 31, 2011
Immunology Revenue 1.19B 834M 986.9M 928.5M 777.8M 866.4M 796.5M 748.1M 1B 785.4M 613.9M 627.1M 548.3M 585.8M 454.6M 456.1M 334.7M 894.5M 966.9M 861.3M 922.6M 759M 887.9M 869.9M 893.7M 964.4M 1.48B 1.88B 2B 1.85B 2.03B 1.82B 1.82B 1.9B 2.65B 53.6M
Immunology Revenue Growth +42.17% -15.49% +6.29% +19.38% -10.23% +8.78% +6.47% -25.55% +27.95% +27.94% -2.10% +14.37% -6.40% +28.86% -0.33% +36.27% -62.58% -7.49% +12.26% -6.64% +21.55% -14.52% +2.07% -2.66% -7.33% -35.05% -20.94% -6.31% +8.42% -8.98% +11.86% -0.48% -4.16% -28.27% +4851.12% n/a
Neuroscience Revenue 351.8M 389.1M 1.77B 387.2M 360.5M 373.2M 389.9M 397.7M 450.2M 512.2M 465.4M 470.7M 422.5M 463.5M 426.7M 452.7M 393.1M 643.7M 721.7M 724.5M 763.9M 725.3M 868.5M 882.4M 858.4M 764.3M 874.4M 821.8M 808.1M 764.2M 839.2M 791.7M 846.8M 803.9M 825.8M 2.41B
Neuroscience Revenue Growth -9.59% -77.99% +356.64% +7.41% -3.40% -4.28% -1.96% -11.66% -12.10% +10.06% -1.13% +11.41% -8.85% +8.62% -5.74% +15.16% -38.93% -10.81% -0.39% -5.16% +5.32% -16.49% -1.58% +2.80% +12.31% -12.59% +6.40% +1.70% +5.74% -8.94% +6.00% -6.51% +5.34% -2.65% -65.66% n/a
Oncology Revenue 2.23B 1.81B 1.75B 1.67B 1.36B 1.29B 1.37B 1.35B 1.41B 1.55B 1.37B 1.33B 1.27B 1.2B 1.15B 1.2B 1.01B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 59.5M 839.9M
Oncology Revenue Growth +23.30% +3.60% +4.55% +23.23% +4.85% -5.51% +1.16% -3.78% -9.52% +13.25% +2.91% +5.11% +5.58% +4.72% -4.16% +18.22% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -92.92% n/a
Other Product Revenue 53.2M 41.3M 42.9M 51M 52.8M 66.6M 80.1M 98.1M 88.8M 64.6M 107.5M 97M 97.6M 174.7M 119.2M 123.3M 113.4M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Product Revenue Growth +28.81% -3.73% -15.88% -3.41% -20.72% -16.85% -18.35% +10.47% +37.46% -39.91% +10.82% -0.61% -44.13% +46.56% -3.33% +8.73% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 30, 2023 Dec 30, 2022 Dec 30, 2021 Dec 30, 2020 Dec 30, 2019 Dec 30, 2018 Dec 30, 2017 Dec 30, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012
China Revenue 1.66B 6.17B 4.3B 4.78B 4.19B 3.77B 4.23B 3.94B 3.77B 3.94B 4.51B 4.34B 4.26B
China Revenue Growth -73.11% +43.62% -10.00% +14.07% +11.23% -11.02% +7.30% +4.65% -4.45% -12.49% +3.88% +1.85% n/a
Europe Revenue 6.92B n/a n/a n/a n/a n/a n/a n/a n/a 2.03B 2.03B n/a n/a
Europe Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a +0.30% n/a n/a n/a
Japan Revenue 1.81B n/a n/a n/a n/a n/a n/a n/a n/a 10.1B 9.13B n/a n/a
Japan Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a +10.55% n/a n/a n/a
United States Revenue 30.38B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.42B 2.1B 2.12B 1.95B 1.92B 1.8B 1.93B 1.75B 1.64B 1.61B 1.63B 1.56B 1.59B 1.58B 1.69B 1.58B 1.55B 1.57B 1.45B 1.55B 1.7B 1.41B 1.59B 1.52B 1.86B 1.62B 1.65B 1.5B 1.78B 1.56B 1.71B 1.54B 1.79B 1.57B 1.62B 1.47B 1.8B 1.58B 1.64B 1.52B
Selling, General, and Administrative Revenue Growth +15.46% -0.83% +8.46% +1.43% +6.69% -6.31% +10.07% +6.45% +1.80% -0.67% +4.31% -2.14% +0.89% -6.39% +6.96% +1.42% -0.97% +8.32% -6.52% -8.75% +20.24% -10.97% +4.56% -18.50% +15.15% -2.24% +10.25% -15.75% +14.46% -8.90% +10.53% -13.71% +14.35% -3.53% +10.09% -18.04% +14.13% -3.65% +7.34% n/a
Research and Development Revenue 3.21B 2.73B 2.71B 2.52B 2.56B 2.41B 2.36B 1.99B 2B 1.8B 1.78B 1.61B 1.96B 1.71B 1.67B 1.68B 1.84B 1.47B 1.39B 1.39B 1.58B 1.38B 1.4B 1.23B 1.45B 1.34B 1.33B 1.18B 1.47B 1.32B 1.25B 1.24B 1.45B 1.24B 1.34B 1.22B 1.44B 1.14B 1.17B 1.04B
Research and Development Revenue Growth +17.47% +0.84% +7.47% -1.56% +6.38% +2.23% +18.71% -0.54% +10.70% +1.18% +10.67% -17.83% +14.66% +2.16% -0.71% -8.34% +25.43% +5.41% -0.14% -11.97% +14.52% -1.52% +13.95% -15.36% +8.23% +0.77% +13.27% -20.11% +11.66% +5.48% +1.02% -14.64% +17.32% -7.45% +9.41% -15.45% +26.31% -2.23% +12.53% n/a
Sales and Marketing Revenue 461.7M n/a 114.4M 116.1M 461.9M n/a n/a n/a 1B 92.4M 94.3M n/a 1.2B n/a 71.1M n/a 1.1B n/a 1.45B 1.55B 1.7B 1.41B 1.59B 1.52B 1.86B 1.62B 1.65B 1.5B 1.78B 1.56B 1.71B 1.54B 1.79B 1.57B 1.62B 1.47B 1.8B 1.58B 1.64B 1.52B
Sales and Marketing Revenue Growth n/a -100.00% -1.46% -74.86% n/a n/a n/a -100.00% +982.25% -2.01% n/a -100.00% n/a -100.00% n/a -100.00% n/a -100.00% -6.52% -8.75% +20.24% -10.97% +4.56% -18.50% +15.15% -2.24% +10.25% -15.75% +14.46% -8.90% +10.53% -13.71% +14.35% -3.53% +10.09% -18.04% +14.13% -3.65% +7.34% n/a

Create Price Alert on LLY

Your price alert will notify you when the stock price is above 839.96.

Add to Watchlist